Developing the evidence base for palliative care: formation of the palliative care research cooperative and its first trial.

PubWeight™: 1.14‹?› | Rank: Top 10%

🔗 View Article (PMC 3929293)

Published in Hosp Pract (1995) on June 01, 2010

Authors

Thomas W LeBlanc1, Jean S Kutner, Danielle Ko, Jane L Wheeler, Janet Bull, Amy P Abernethy

Author Affiliations

1: Division of Medical Oncology, Department of Medicine, Duke University Medical Center, Durham, NC 27710, USA.

Articles cited by this

MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial. Lancet (2002) 44.28

A short portable mental status questionnaire for the assessment of organic brain deficit in elderly patients. J Am Geriatr Soc (1975) 21.45

Prevention of coronary and stroke events with atorvastatin in hypertensive patients who have average or lower-than-average cholesterol concentrations, in the Anglo-Scandinavian Cardiac Outcomes Trial--Lipid Lowering Arm (ASCOT-LLA): a multicentre randomised controlled trial. Lancet (2003) 17.34

Processes to activate phase III clinical trials in a Cooperative Oncology Group: the Case of Cancer and Leukemia Group B. J Clin Oncol (2006) 4.91

The growth of palliative care programs in United States hospitals. J Palliat Med (2005) 3.00

Development of clinical trials in a cooperative group setting: the eastern cooperative oncology group. Clin Cancer Res (2008) 2.89

Discontinuing cardiovascular medications at the end of life: lipid-lowering agents. J Palliat Med (2005) 2.65

Risk for myopathy with statin therapy in high-risk patients. Arch Intern Med (2003) 2.56

Statins in stroke prevention and carotid atherosclerosis: systematic review and up-to-date meta-analysis. Stroke (2004) 2.41

Methodologic issues in effectiveness research on palliative cancer care: a systematic review. J Clin Oncol (1997) 2.23

Utility of the "surprise" question to identify dialysis patients with high mortality. Clin J Am Soc Nephrol (2008) 2.22

The Australia-modified Karnofsky Performance Status (AKPS) scale: a revised scale for contemporary palliative care clinical practice [ISRCTN81117481]. BMC Palliat Care (2005) 2.17

Safety of atorvastatin derived from analysis of 44 completed trials in 9,416 patients. Am J Cardiol (2003) 1.96

FDA adverse event reports on statin-associated rhabdomyolysis. Ann Pharmacother (2002) 1.67

Managing comorbidities in patients at the end of life. BMJ (2004) 1.59

A pragmatic 2 x 2 x 2 factorial cluster randomized controlled trial of educational outreach visiting and case conferencing in palliative care-methodology of the Palliative Care Trial [ISRCTN 81117481]. Contemp Clin Trials (2005) 1.51

Changes in the quantity and level of evidence of palliative and hospice care literature: the last century. J Clin Oncol (2008) 1.29

Statins in the last six months of life: a recognizable, life-limiting condition does not decrease their use. J Palliat Med (2008) 1.19

Asking the right question. J Palliat Med (2001) 1.04

Recruiting older people into a large, community-based study of heart failure. Chronic Illn (2005) 1.01

Enhancing enrollment in palliative care trials: key insights from a randomized, placebo-controlled study. J Support Oncol (2010) 0.99

Palliative care clinical research networks, a requirement for evidence-based palliative care: time for coordinated action. J Palliat Med (2007) 0.96

A comparison of methodologies from two longitudinal community-based randomized controlled trials of similar interventions in palliative care: what worked and what did not? J Palliat Med (2005) 0.87

When statin therapy stops: implications for the patient. Curr Opin Cardiol (2009) 0.85

Articles by these authors

American Society of Clinical Oncology provisional clinical opinion: the integration of palliative care into standard oncology care. J Clin Oncol (2012) 7.54

Reduction of cancer-related fatigue with dexamethasone: a double-blind, randomized, placebo-controlled trial in patients with advanced cancer. J Clin Oncol (2013) 5.07

The financial toxicity of cancer treatment: a pilot study assessing out-of-pocket expenses and the insured cancer patient's experience. Oncologist (2013) 4.33

Generalist plus specialist palliative care--creating a more sustainable model. N Engl J Med (2013) 4.27

Safety of benzodiazepines and opioids in very severe respiratory disease: national prospective study. BMJ (2014) 3.75

Improving the quality of spiritual care as a dimension of palliative care: the report of the Consensus Conference. J Palliat Med (2009) 3.46

Toward a common taxonomy of competency domains for the health professions and competencies for physicians. Acad Med (2013) 3.08

Oncologist communication about emotion during visits with patients with advanced cancer. J Clin Oncol (2007) 3.07

Effect of palliative oxygen versus room air in relief of breathlessness in patients with refractory dyspnoea: a double-blind, randomised controlled trial. Lancet (2010) 3.07

Psychological interventions for arthritis pain management in adults: a meta-analysis. Health Psychol (2007) 2.92

Characteristics of oncology clinical trials: insights from a systematic analysis of ClinicalTrials.gov. JAMA Intern Med (2013) 2.86

Recommendations for incorporating patient-reported outcomes into clinical comparative effectiveness research in adult oncology. J Clin Oncol (2012) 2.82

Stage migration, selection bias, and survival associated with the adoption of positron emission tomography among medicare beneficiaries with non-small-cell lung cancer, 1998-2003. J Clin Oncol (2012) 2.72

Changes in the use and costs of diagnostic imaging among Medicare beneficiaries with cancer, 1999-2006. JAMA (2010) 2.68

Effect of Spanish interpretation method on patient satisfaction in an urban walk-in clinic. J Gen Intern Med (2002) 2.55

Recommendations for clinical trials of off-label drugs used to treat advanced-stage cancer. J Clin Oncol (2012) 2.15

Rapid, responsive, relevant (R3) research: a call for a rapid learning health research enterprise. Clin Transl Med (2013) 2.10

Brief communication: Management of implantable cardioverter-defibrillators in hospice: A nationwide survey. Ann Intern Med (2010) 1.98

Promoting patient centred palliative care through case conferencing. Aust Fam Physician (2007) 1.98

Caring for cancer survivors: a survey of primary care physicians. Cancer (2009) 1.92

Full disclosure--out-of-pocket costs as side effects. N Engl J Med (2013) 1.90

Psychological approaches to understanding and treating disease-related pain. Annu Rev Psychol (2005) 1.87

Development of a subject search filter to find information relevant to palliative care in the general medical literature. J Med Libr Assoc (2006) 1.82

Enhancing communication between oncologists and patients with a computer-based training program: a randomized trial. Ann Intern Med (2011) 1.78

Symptoms, depression, and quality of life in patients with heart failure. J Card Fail (2007) 1.77

Use of tablet personal computers for sensitive patient-reported information. J Support Oncol (2009) 1.73

Prescribing in palliative care as death approaches. J Am Geriatr Soc (2007) 1.68

Electronic patient-reported data capture as a foundation of rapid learning cancer care. Med Care (2010) 1.67

Improving health care efficiency and quality using tablet personal computers to collect research-quality, patient-reported data. Health Serv Res (2008) 1.65

Health care for older Americans with multiple chronic conditions: a research agenda. J Am Geriatr Soc (2007) 1.65

A strategy to advance the evidence base in palliative medicine: formation of a palliative care research cooperative group. J Palliat Med (2010) 1.64

A national snapshot of satisfaction with breast cancer procedures. Ann Surg Oncol (2014) 1.62

Symptom burden, depression, and spiritual well-being: a comparison of heart failure and advanced cancer patients. J Gen Intern Med (2009) 1.62

Defining best supportive care. J Clin Oncol (2008) 1.60

Managing comorbidities in patients at the end of life. BMJ (2004) 1.59

Handheld computers for data entry: high tech has its problems too. Trials (2007) 1.57

Fatigue is the most important symptom for advanced cancer patients who have had chemotherapy. J Natl Compr Canc Netw (2008) 1.55

Systematic review: reliability of compendia methods for off-label oncology indications. Ann Intern Med (2009) 1.55

Dyspnea review for the palliative care professional: treatment goals and therapeutic options. J Palliat Med (2012) 1.54

Patient preference in the decision to place implantable cardioverter-defibrillators. Arch Intern Med (2012) 1.53

Factors influencing models of end-of-life care in nursing homes: results of a survey of nursing home administrators. J Palliat Med (2004) 1.53

Analyzing phase III studies in hospice/palliative care. a solution that sits between intention-to-treat and per protocol analyses: the palliative-modified ITT analysis. J Pain Symptom Manage (2012) 1.53

Feasibility and acceptability to patients of a longitudinal system for evaluating cancer-related symptoms and quality of life: pilot study of an e/Tablet data-collection system in academic oncology. J Pain Symptom Manage (2009) 1.45

Once-daily opioids for chronic dyspnea: a dose increment and pharmacovigilance study. J Pain Symptom Manage (2011) 1.42

Supporting clinical practice decisions with real-time patient-reported outcomes. J Clin Oncol (2011) 1.41

Importance of health information technology, electronic health records, and continuously aggregating data to comparative effectiveness research and learning health care. J Clin Oncol (2012) 1.41

Methadone. Am J Hosp Palliat Care (2008) 1.40

Estimation of confusion prevalence in hospice patients. J Palliat Med (2002) 1.40

Hospice pharmaceutical cost trends. Am J Hosp Palliat Care (2004) 1.40

Validation of the Patient Care Monitor (Version 2.0): a review of system assessment instrument for cancer patients. J Pain Symptom Manage (2010) 1.39

Do the trajectories of dyspnea differ in prevalence and intensity by diagnosis at the end of life? A consecutive cohort study. J Pain Symptom Manage (2010) 1.37

Studying communication in oncologist-patient encounters: the SCOPE Trial. Palliat Med (2006) 1.37

Palliative care education: an intervention to improve medical residents' knowledge and attitudes. J Palliat Med (2003) 1.35

Financial toxicity, Part I: a new name for a growing problem. Oncology (Williston Park) (2013) 1.33

Focus group findings about the influence of culture on communication preferences in end-of-life care. J Gen Intern Med (2005) 1.32

Variations in use of PET among Medicare beneficiaries with non-small cell lung cancer, 1998-2007. Radiology (2013) 1.30

Association between the Medicare Modernization Act of 2003 and patient wait times and travel distance for chemotherapy. JAMA (2008) 1.28

Patient-oncologist communication in advanced cancer: predictors of patient perception of prognosis. Support Care Cancer (2008) 1.27

Prognostic significance of functional capacity and exercise behavior in patients with metastatic non-small cell lung cancer. Lung Cancer (2011) 1.26

A practical tool to identify patients who may benefit from a palliative approach: the CARING criteria. J Pain Symptom Manage (2006) 1.25

Consensus-based standards for best supportive care in clinical trials in advanced cancer. Lancet Oncol (2012) 1.23

Decision making and quality of life in the treatment of cancer: a review. Support Care Cancer (2008) 1.19

Specialized palliative care services are associated with improved short- and long-term caregiver outcomes. Support Care Cancer (2007) 1.19

Patient experiences with communication about sex during and after treatment for cancer. Psychooncology (2011) 1.17

Exploring the generalist-subspecialist interface in internal medicine. Am J Med (2006) 1.17

A framework for generalizability in palliative care. J Pain Symptom Manage (2008) 1.17

Longitudinal patient-reported performance status assessment in the cancer clinic is feasible and prognostic. J Oncol Pract (2011) 1.17

Minimization of heatwave morbidity and mortality. Am J Prev Med (2013) 1.16

Patient and cardiologist perceptions on decision making for implantable cardioverter-defibrillators: a qualitative study. Pacing Clin Electrophysiol (2011) 1.16

Hospices' preparation and practices for quality measurement. J Pain Symptom Manage (2010) 1.14

"Not the 'grim reaper service'": an assessment of provider knowledge, attitudes, and perceptions regarding palliative care referral barriers in heart failure. J Am Heart Assoc (2014) 1.14

A community population survey of prevalence and severity of dyspnea in adults. J Pain Symptom Manage (2009) 1.14

The Medicare Modernization Act and reimbursement for outpatient chemotherapy: do patients perceive changes in access to care? Cancer (2007) 1.13

Self-reported financial burden and satisfaction with care among patients with cancer. Oncologist (2014) 1.13

CareSearch: finding and evaluating Australia's missing palliative care literature. BMC Palliat Care (2005) 1.12

Patient navigation: a culturally competent strategy to address disparities in palliative care. J Palliat Med (2007) 1.12

Specialist palliative care needs of whole populations: a feasibility study using a novel approach. Palliat Med (2004) 1.11

Longitudinal patterns of chemotherapy use in metastatic colorectal cancer. J Oncol Pract (2009) 1.10

Hospital can be the actively chosen place for death. J Clin Oncol (2013) 1.09

Uncovering an invisible network of direct caregivers at the end of life: a population study. Palliat Med (2013) 1.09

Unmet spiritual care needs impact emotional and spiritual well-being in advanced cancer patients. Support Care Cancer (2011) 1.08

Management of gastrointestinal symptoms in advanced cancer patients: the rapid learning cancer clinic model. Curr Opin Support Palliat Care (2010) 1.08

Indwelling catheters for the management of refractory malignant ascites: a systematic literature overview and retrospective chart review. J Pain Symptom Manage (2009) 1.08

Stakeholder perspectives on implementing the National Cancer Institute's patient-reported outcomes version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE). Transl Behav Med (2011) 1.07

Timing of end-of-life care discussion with performance on end-of-life quality indicators in ovarian cancer. Gynecol Oncol (2013) 1.07

Populations who die without specialist palliative care: does lower uptake equate with unmet need? Palliat Med (2008) 1.06

Electronic toxicity monitoring and patient-reported outcomes. Cancer J (2011) 1.06

Establishing a regional, multisite database for quality improvement and service planning in community-based palliative care and hospice. J Palliat Med (2010) 1.06

Developing quality indicators for cancer end-of-life care: proceedings from a national symposium. Cancer (2009) 1.05

Post-traumatic stress symptoms in long-term non-Hodgkin's lymphoma survivors: does time heal? J Clin Oncol (2011) 1.03